Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antimicrobial Agents and Chemotherapy 1993-06, Vol.37 (6), p.1334-1342
Hauptverfasser:	WALSH, T. J, STANDIFORD, H. C, STEVENS, D. A, HANSEN, S. L, GERARD, G. C, RAGUAL, R. J, REBOLI, A. C, JOHN, J. F, MULLIGAN, M. E, RIBNER, B. S, MONTGOMERIE, J. Z, GOETZ, M. B, MAYHALL, C. G, RIMLAND, D
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences DNA, Neoplasm - analysis Double-Blind Method Drug Therapy, Combination Drug Therapy, Combination - adverse effects Drug Therapy, Combination - therapeutic use Female Humans Male Medical sciences Methicillin Resistance Middle Aged Nasal Cavity - microbiology Novobiocin - adverse effects Novobiocin - therapeutic use Outcome Assessment (Health Care) Pharmacology. Drug treatments Research Article Rifampin - therapeutic use Staphylococcal Infections Staphylococcal Infections - drug therapy Staphylococcus aureus Trimethoprim, Sulfamethoxazole Drug Combination - adverse effects Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use Wound Infection Wound Infection - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!